Erin Golembewski, Ph.D.
Affiliations: | 2006 | University of Maryland School of Medicine, Baltimore, MD, United States |
Area:
Pharmacology, Neuroscience Biology, Virology BiologyGoogle:
"Erin Golembewski"Mean distance: 53433
Parents
Sign in to add mentor| Paul J. Yarowsky | grad student | 2006 | University of Maryland Medical School | |
| (The HSV -2 protein ICP10PK protects CNS neurons from NMDA-induced excitotoxicity in vitro and in vivo.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Laing JM, Golembewski EK, Wales SQ, et al. (2008) Growth-compromised HSV-2 vector Delta RR protects from N-methyl-D-aspartate-induced neuronal degeneration through redundant activation of the MEK/ERK and PI3-K/Akt survival pathways, either one of which overrides apoptotic cascades. Journal of Neuroscience Research. 86: 378-91 |
| Laing JM, Gober MD, Golembewski EK, et al. (2007) Corrigendum to "Intranasal Administration of the Growth-compromised HSV-2 Vector ΔRR Prevents Kainate-induced Seizures and Neuronal Loss in Rats and Mice". Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1734 |
| Golembewski EK, Wales SQ, Aurelian L, et al. (2007) The HSV-2 protein ICP10PK prevents neuronal apoptosis and loss of function in an in vivo model of neurodegeneration associated with glutamate excitotoxicity. Experimental Neurology. 203: 381-93 |
| Laing JM, Gober MD, Golembewski EK, et al. (2006) Intranasal administration of the growth-compromised HSV-2 vector DeltaRR prevents kainate-induced seizures and neuronal loss in rats and mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 870-81 |